Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of International Oncology
>
2016
>
43
>
9
Volume:
43
Issue:
9
1. Changes of bone marrow microenvironment of myelodysplastic syndromes
Page:715—717
2. Research progress of thalidomide in usual non-hematologic malignancies
Page:711—714
3. Research in thyroid carcinoma related factors
Page:695—698
4. Models and mechanisms of collective cell migration in cancer
Page:691—694
5. Neoplasms chemosensitization enhancing effects of nitric oxide donor compounds
Page:684—687
6. Roles of microRNAs in the anti-tumor effects of metformin
Page:681—683
7. Relationship among pyroptosis,inflammasome and tumor
Page:676—680
8. Expression and role of SPARCL1 gene in tumor
Page:673—675
9. Clinical observation of raltitrexed combined with irinotecan as first-line chemotherapy for recurrent or metastatic gastric cancer
Page:669—672
10. Relationships between androgen receptor expression and clinicopathological features and prognosis of early-onset breast cancer in Xinjiang
Page:651—654
11. Construction of colonic cancer drug-resistant cell line COLO and its relationship with tumor stem cells
Page:646—650
12. Long non-coding RNA in digestive system tumors
Page:706—710
13. Relationship between abnormal activation of HGF/c-Met signaling pathway and EGFR-TKI acquired resistance in non-small cell lung cancer
Page:703—705
14. The correlation of PIK3CA gene mutation and the efficacy of anti-HER2 targeted therapy for breast cancer
Page:699—702
15. Behavior of cancers evolution
Page:688—690
16. Expressions and clinicopathological significances of BMI-1 and PADI4 in esophageal squamous cell car-cinoma
Page:664—668
17. Comparison of clinical efficacy of gefitinib and erlotinib treating non-small-cell lung cancer with epider-mal growth factor receptor mutation in either exon 19 or 21
Page:659—663
18. Expression and significance of MET gene in non-small cell lung cancer
Page:655—658
19. Study of transferrin modified doxorubicin liposome targeted to inhibit proliferation of breast cancer cells
Page:641—645